ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 115 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $256,000 | -97.1% | 4,828 | -93.9% | 0.00% | -100.0% |
| Q4 2015 | $8,916,000 | +457.9% | 79,611 | +482.8% | 0.01% | +450.0% |
| Q3 2015 | $1,598,000 | +616.6% | 13,660 | +370.4% | 0.00% | – |
| Q2 2015 | $223,000 | -82.3% | 2,904 | -86.9% | 0.00% | -100.0% |
| Q1 2015 | $1,259,000 | +876.0% | 22,091 | +442.8% | 0.00% | – |
| Q4 2014 | $129,000 | +6.6% | 4,070 | -19.4% | 0.00% | – |
| Q3 2014 | $121,000 | -19.3% | 5,050 | -42.6% | 0.00% | – |
| Q2 2014 | $150,000 | -63.9% | 8,795 | -57.7% | 0.00% | – |
| Q1 2014 | $416,000 | +684.9% | 20,787 | +526.1% | 0.00% | – |
| Q4 2013 | $53,000 | -84.0% | 3,320 | -90.0% | 0.00% | – |
| Q3 2013 | $332,000 | +876.5% | 33,292 | +447.0% | 0.00% | – |
| Q2 2013 | $34,000 | – | 6,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |